Option Care Health Is Moving Infusion to Your Living Room—Can This Bold Bet Transform U.S. Healthcare?

Option Care Health delivered a solid first quarter of 2025, with revenues rising by 16% over the year-ago quarter. The growth was well-balanced, with mid-teens expansion in acute therapies and high-teens growth in chronic therapies. The company capitalized on improved IV bag supply and continued investments in infrastructure to respond effectively to dynamic market demands. The performance reflects Option Care Health’s robust clinical capabilities and scale, valuable in adapting to market shifts and supporting patient transitions from hospitals to home care.